首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites
【24h】

Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites

机译:液相色谱串联质谱法测定尿中游离的肾上腺素和儿茶酚胺,并比较游离和结合的代谢物

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: We introduce a novel liquid chromatographic tandem-mass spectrometric method for simultaneous measurements of urinary catecholamines and their free O-methylated metabolites, which we compare to the deconjugated metabolites. Methods: Method performance was validated for recovery, linearity, precision and accuracy, analyte stability, ion suppression and carry over. Results from 53 patients with and 138 volunteers without pheochromocytoma were compared. Results: Analyte recoveries ranged from 60 to 96% and intra- and inter-assay coefficients of variation from 2.7 to 13.2%. The method showed excellent linearity over 3 orders of magnitude with analytical sensitivity sufficient to measure to 1.2. nmol/L. Free O-methylated metabolites were excreted at less than 20% the rates of the deconjugated metabolites, but were easily measureable. Increases in urinary normetanephrine in pheochromocytoma patients relative to volunteers were higher for free than deconjugated metabolites and higher for both than for norepinephrine (10 vs 5.5 vs 3.7 fold increases). In contrast, relative increases in urinary free versus deconjugated metanephrine (2.7 and 3.2) and methoxytyramine (2.1 and 1.9) did not differ, but for methoxytyramine were larger than for dopamine (1.2). Conclusion: Measurements of urinary catecholamines and their free O-methylated metabolites by our method provide potential advantages over urinary deconjugated metanephrines for diagnosis of pheochromocytoma. ? 2013 Elsevier B.V.
机译:目的:介绍一种同时测定尿中儿茶酚胺及其游离O-甲基化代谢产物的液相色谱-串联质谱法,并将其与解偶联代谢物进行比较。方法:验证了方法的性能,包括回收率,线性,精密度和准确性,分析物稳定性,离子抑制和残留。比较了53名有嗜铬细胞瘤的患者和138名无嗜铬细胞瘤的志愿者的结果。结果:分析物的回收率在60%到96%之间,测定内和测定间的变异系数在2.7%到13.2%之间。该方法在3个数量级上显示出出色的线性,分析灵敏度足以测量到1.2。 nmol / L。游离O-甲基化代谢产物的排泄率低于解偶联代谢产物的20%,但很容易测量。相对于志愿者,嗜铬细胞瘤患者尿中的去甲肾上腺素的升高高于游离的代谢产物,两者均高于去甲肾上腺素(升高10倍,5.5倍和3.7倍)。相比之下,游离尿与解偶联的肾上腺素(2.7和3.2)和甲氧基酪胺(2.1和1.9)的相对增加没有差异,但甲氧基酪胺的多于多巴胺(1.2)。结论:通过我们的方法测定尿儿茶酚胺及其游离的O-甲基化代谢产物,在诊断嗜铬细胞瘤方面比尿解离的间肾上腺素具有潜在的优势。 ? 2013 Elsevier B.V.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号